I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Karokis, A
62
results:
Search for persons
X
Format
Online (62)
Mediatypes
Articles (Online) (50)
OpenAccess-fulltext (12)
Sorted by: Relevance
Sorted by: Year
?
1
EE210 Cost-Effectiveness Analysis of Pembrolizumab Plus Che..:
Yfantopoulos, N.
;
Athanasopoulos, C.
;
Haiderali, A.
...
Value in Health. 26 (2023) 12 - p. S91 , 2023
Link:
https://doi.org/10.1016/..
?
2
EE444 Cost-Effectiveness Analysis of Replacing PCV13 with P..:
Gountas, I.
;
Yfantopoulos, N.
;
Trimis, G.
...
Value in Health. 26 (2023) 12 - p. S136-S137 , 2023
Link:
https://doi.org/10.1016/..
?
3
EE672 Cost-Effectiveness Analysis of Pembrolizumab for the ..:
Yfantopoulos, N.
;
Emmanouil, G.
;
Skroumpelos, A.
.
Value in Health. 26 (2023) 12 - p. S183 , 2023
Link:
https://doi.org/10.1016/..
?
4
HPR96 Pieces: Productivity Losses Due to Premature Mortalit..:
Yfantopoulos, N.
;
Skroumpelos, A.
;
Karokis, A.
...
Value in Health. 26 (2023) 12 - p. S270 , 2023
Link:
https://doi.org/10.1016/..
?
5
EE370 Cost-Effectiveness Analysis of Pembrolizumab as Adjuv..:
Yfantopoulos, N.
;
Spanoudi, F.
;
Draganigos, A.
..
Value in Health. 26 (2023) 12 - p. S122 , 2023
Link:
https://doi.org/10.1016/..
?
6
EPH265 Updated Estimations of the HPV Vaccination Deficit A..:
Gountas, I.
;
Skroumpelos, A.
;
Trimis, G.
...
Value in Health. 26 (2023) 12 - p. S251-S252 , 2023
Link:
https://doi.org/10.1016/..
?
7
EE66 Cost Effectiveness Analysis of Pembrolizumab as First-..:
Yfantopoulos, N.
;
Gountas, I.
;
Swami, S.
..
Value in Health. 26 (2023) 12 - p. S62 , 2023
Link:
https://doi.org/10.1016/..
?
8
EE293 Estimation of the Cost of the National Immunization P..:
Gountas, I.
;
Mylonas, C.
;
Trimis, G.
...
Value in Health. 26 (2023) 12 - p. S107 , 2023
Link:
https://doi.org/10.1016/..
?
9
EE678 Time and Cost Savings from Adopting an Alternative Do..:
Draganigos, A.
;
Yfantopoulos, N.
;
Skroumpelos, A.
..
Value in Health. 26 (2023) 12 - p. S184 , 2023
Link:
https://doi.org/10.1016/..
?
10
EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Ta..:
Yfantopoulos, N
;
Bafaloukos, I
;
Yang, J
...
Value in Health. 25 (2022) 12 - p. S131 , 2022
Link:
https://doi.org/10.1016/..
?
11
HPR142 The Impact of Cost-Shifting Policies on the Pharmace..:
Konstantopoulos, A
;
Chantzaras, A
;
Ktena, D
..
Value in Health. 25 (2022) 12 - p. S258 , 2022
Link:
https://doi.org/10.1016/..
?
12
HPR15 Out-of-Pocket Pharmaceutical Payments and Their Pover..:
Yfantopoulos, I
;
Chantzaras, A
;
Konstantopoulos, A
..
Value in Health. 25 (2022) 12 - p. S234-S235 , 2022
Link:
https://doi.org/10.1016/..
?
13
EE651 Cost-Effectiveness Analysis of Pembrolizumab Plus Che..:
Yfantopoulos, N
;
Gountas, I
;
Athanasopoulos, C
...
Value in Health. 25 (2022) 12 - p. S184 , 2022
Link:
https://doi.org/10.1016/..
?
14
HPR101 Analyzing Substitution Effects in Financing of the P..:
Yfantopoulos, I
;
Chantzaras, A
;
Konstantopoulos, A
..
Value in Health. 25 (2022) 12 - p. S250 , 2022
Link:
https://doi.org/10.1016/..
?
15
EE248 Cost Effectiveness of Novel Antiobiotic Imipenem/Cila..:
Yfantopoulos, N
;
Bafaloukos, I
;
Ntontsi, P
...
Value in Health. 25 (2022) 12 - p. S102 , 2022
Link:
https://doi.org/10.1016/..
1-15